56.76
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRSP Giù?
Forum
Previsione
Crispr Therapeutics Ag Borsa (CRSP) Ultime notizie
Sumitomo Mitsui Trust Group Inc. Sells 205,564 Shares of CRISPR Therapeutics AG $CRSP - MarketBeat
CRISPR Therapeutics Touts “Second Phase” After Casgevy, Eyes 6 Data Readouts in 6–12 Months - MarketBeat
CRISPR Therapeutics Improves Cash Position Amid Pipeline Expansion - Intellectia AI
2 Billion Reasons to Love CRISPR Therapeutics Right Now - The Motley Fool
Momentum Shift: Is CRISPR Therapeutics AG a strong growth stock2026 Update & Safe Capital Investment Plans - baoquankhu1.vn
Published on: 2026-04-13 17:48:33 - baoquankhu1.vn
Aug Highlights: What is the long term forecast for CRISPR Therapeutics AG stockMarket Sentiment Review & Entry Point Strategy Guides - baoquankhu1.vn
CRISPR Therapeutics AG (CRSP) is attracting investor attention: Here is what you should know - MSN
Is CRISPR Therapeutics (CRSP) Pricing In Too Much Hope After Recent Share Price Recovery - Yahoo Finance
CRISPR’s One-Time ANGPTL3 Edit for Lipids Might Change The Case For Investing In CRISPR Therapeutics (CRSP) - Sahm
Bank Watch: What is the long term forecast for CRISPR Therapeutics AG stockWeekly Stock Report & Daily Market Momentum Tracking - baoquankhu1.vn
Is CRISPR Therapeutics AG a strong growth stock2026 Technical Patterns & Expert Approved Trade Ideas - baoquankhu1.vn
symbol__ Stock Quote Price and Forecast - CNN
CRSP Stock Price, Quote & Chart | CRISPR THERAPEUTICS AG (NASDAQ:CRSP) - ChartMill
Why is CRISPR Therapeutics AG stock going down2026 Technical Patterns & Daily Growth Stock Investment Tips - baoquankhu1.vn
Is CRISPR Therapeutics (CRSP) Pricing Reflect Its Sharp Five‑Year Share Price Pullback - simplywall.st
Bank of America Securities Remains a Buy on Crispr Therapeutics AG (CRSP) - The Globe and Mail
Price-Driven Insight from (CRSP) for Rule-Based Strategy - Stock Traders Daily
CRISPR Therapeutics AG (CRSP) Stock Price, News, Quote & History - Yahoo! Finance Canada
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Sell Signal: Should I set a stop loss on CRISPR Therapeutics AG2026 Volume Leaders & Proven Capital Preservation Methods - baoquankhu1.vn
CRISPR Therapeutics: Potential Breakthroughs in Gene Editing - Intellectia AI
Can CRISPR Therapeutics AG stock outperform in a bear marketStock Surge & Long-Term Capital Growth Ideas - baoquankhu1.vn
Del-Sette Capital Management, LLC's CRISPR Therapeutics AG(CRSP) Holding History - GuruFocus
CRISPR Therapeutics AG (CRSP) stock price, news, quote and history - sg.finance.yahoo.com
CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference - The Manila Times
Genome Editing Market Is Going to Boom |• CRISPR Therapeutics • Editas Medicine - openPR.com
CRISPR Therapeutics AG (CRSP) latest stock news and headlines - Yahoo Finance Australia
Assessing CRISPR Therapeutics (CRSP) Valuation As Casgevy Revenue And Cash Position Support Its Growth Transition - Sahm
LTS:0VRQ PB Ratio: 2.47 — 22% Below Median - GuruFocus
CRISPR Therapeutics Hits Day Low of $50.66 Amid Price Pressure - Markets Mojo
Did CRISPR’s Cash Raise, Casgevy Launch and Insider Buying Just Shift CRISPR Therapeutics' (CRSP) Investment Narrative? - Sahm
CRISPR Therapeutics AG (CRSP) rises higher than market: Key facts - MSN
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):